For the treatment of ovarian cancer, this phenomenon was investigated in an in vitro study, where the polyphenol gallic acid at 40 μM inhibited VEGF in A2780/CP70 and OVCAR-3 cells by 24.05 and 27.12%, respectively [98]. This evidence concerns the gene VEGFA and ovarian cancer.